Flunitrazepam and Metabolites, Quantitative

The Flunitrazepam and Metabolites, Quantitative test contains 1 test with 3 biomarkers.

In Latin America and Europe, Rohypnol (Flunitrazepam) is prescribed as a short-term treatment for insomnia, and as preanesthetic medication. Flunitrazepam is considered a drug of abuse when used to enhance the effect of other substances such as marijuana, heroin, and ethanol. The combination of ethanol and flunitrazepam may lead to sedation, loss of motor function, impaired judgment, behavioral changes, and anterograde amnesia.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Flunitrazepam and Metabolites Quantitative

Flunitrazepam And

7 Amnioflunitrazepam

N Desmethylflunitrazepam